In addition, at the boundary between tumour and normal tissue, some stromal cells or myeloid cells recruited by CD4+T cells can bypass MHC-I molecules and present tumour antigens to CD4+T cells via MHC-II molecules. Here, CD4 is linked to neoplasm.